Articles published by Genmab A/S![]()
Genmab Announces Financial Results for the First Nine Months of 2023
November 07, 2023
From Genmab A/S
Via GlobeNewswire
![]() ![]() From Genmab A/S
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
Genmab Announces Financial Results for the First Half of 2023
August 03, 2023
From Genmab A/S
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() From Genmab A/S
Via GlobeNewswire
![]() ![]() ![]() From Genmab A/S
Via GlobeNewswire
![]() ![]()
Genmab Announces Initiation of Share Buy-Back Program
February 22, 2023
From Genmab A/S
Via GlobeNewswire
![]() ![]()
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
January 24, 2023
From Genmab A/S
Via GlobeNewswire
![]() ![]() ![]()
Genmab Announces Financial Results for the First Nine Months of 2022
November 09, 2022
From Genmab A/S
Via GlobeNewswire
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|